SCHEMBL6783105

SCHEMBL6783105

CC(C#N)[CH]C#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL130332 0.72
SCHEMBL269948 0.69
SCHEMBL1435402 0.69
SCHEMBL11298691 0.69
SCHEMBL214876 0.67
SCHEMBL2558387 0.67
SCHEMBL27505449 0.67
SCHEMBL18632230 0.67
SCHEMBL18550127 0.67
SCHEMBL17400860 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10988482-B2 IRAK4 inhibitor and use thereof Beijing Hanmi Pharmaceutical Co., Ltd. (CN) 2021-04-27 US disclosed
CN-107531725-B IRAK4 inhibitor and application thereof 北京韩美药品有限公司 2021-03-19 CN disclosed
EP-3336091-B1 IRAK4 INHIBITOR AND USE THEREOF BEIJING HANMI PHARMACEUTICAL CO LTD (CN) 2020-12-02 EP disclosed
US-20200062775-A1 IRAK4 INHIBITOR AND USE THEREOF Beijing Hanmi Pharmaceutical Co., Ltd. (CN) 2020-02-27 US disclosed
EP-3336091-A1 IRAK4 INHIBITOR AND USE THEREOF Beijing Hanmi Pharmaceutical Co., Ltd. (CN) 2018-06-20 EP disclosed
CN-107531725-A Irak4 inhibitor and application thereof 北京韩美药品有限公司 2018-01-02 CN disclosed
CN-105609649-A Organic electroluminescent device SAMSUNG DISPLAY CO LTD 2016-05-25 CN disclosed
US-6809101-B2 RNA POLYMERASES INHIBITORS; SUCH AS 5-(1-HYDROXY-1-(5-METHYL-OXAZOL-2-YL))METHYLENE-2-THIOXOTHIAZOLIDIN-4-ONE SHIONOGI & CO., LTD. (JP) 2004-10-26 US disclosed
US-20030203948-A1 Compounds having anti-hepatitics c virus effect Z-KAT, INC. 2003-10-30 US disclosed
CN-1304410-A Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them ASTRA ZENECA LTD (SE) 2001-07-18 CN disclosed